Orion Portfolio Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.16M | Sell |
1,830
-252
| -12% | -$160K | 0.01% | 1002 |
|
|
2024
Q4 | $1.48M | Sell |
2,082
-489
| -19% | -$348K | 0.01% | 842 |
|
|
2024
Q3 | $2.7M | Sell |
2,571
-302
| -11% | -$317K | 0.03% | 542 |
|
|
2024
Q2 | $3.02M | Buy |
2,873
+138
| +5% | +$145K | 0.03% | 473 |
|
|
2024
Q1 | $2.63M | Sell |
2,735
-36
| -1% | -$34.6K | 0.03% | 528 |
|
|
2023
Q4 | $2.5M | Sell |
2,771
-12,934
| -82% | -$11.7M | 0.03% | 534 |
|
|
2023
Q3 | $12.9M | Sell |
15,705
-1,109
| -7% | -$913K | 0.16% | 138 |
|
|
2023
Q2 | $12.1M | Sell |
16,814
-458
| -3% | -$329K | 0.13% | 153 |
|
|
2023
Q1 | $14.2M | Buy |
17,272
+15,715
| +1,009% | +$12.9M | 0.18% | 122 |
|
|
2022
Q4 | $1.12M | Buy |
1,557
+168
| +12% | +$121K | 0.04% | 279 |
|
|
2022
Q3 | $957K | Buy |
1,389
+310
| +29% | +$214K | 0.04% | 276 |
|
|
2022
Q2 | $638K | Buy |
1,079
+117
| +12% | +$69.2K | 0.03% | 345 |
|
|
2022
Q1 | $672K | Buy |
962
+20
| +2% | +$14K | 0.02% | 352 |
|
|
2021
Q4 | $595K | Sell |
942
-381
| -29% | -$241K | 0.02% | 383 |
|
|
2021
Q3 | $801K | Buy |
1,323
+747
| +130% | +$452K | 0.03% | 293 |
|
|
2021
Q2 | $322K | Buy |
576
+2
| +0.3% | +$1.12K | 0.01% | 470 |
|
|
2021
Q1 | $272K | Sell |
574
-2,518
| -81% | -$1.19M | 0.01% | 461 |
|
|
2020
Q4 | $1.49M | Buy |
3,092
+1,010
| +49% | +$488K | 0.07% | 155 |
|
|
2020
Q3 | $1.17M | Buy |
2,082
+1,770
| +567% | +$990K | 0.06% | 170 |
|
|
2020
Q2 | $195K | Buy |
312
+122
| +64% | +$76.3K | 0.01% | 413 |
|
|
2020
Q1 | $93K | Buy |
190
+33
| +21% | +$16.2K | 0.01% | 459 |
|
|
2019
Q4 | $59K | Buy |
+157
| New | +$59K | ﹤0.01% | 523 |
|